HK157896A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
HK157896A
HK157896A HK157896A HK157896A HK157896A HK 157896 A HK157896 A HK 157896A HK 157896 A HK157896 A HK 157896A HK 157896 A HK157896 A HK 157896A HK 157896 A HK157896 A HK 157896A
Authority
HK
Hong Kong
Prior art keywords
active agent
polymer
bopindolol
composition according
transdermal
Prior art date
Application number
HK157896A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kissel Thomas
Schrank Henriette
Hoffmann Hans-Rainer
Original Assignee
Sandoz Ag
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Lts Lohmann Therapie-Systeme Gmbh & Co. Kg filed Critical Sandoz Ag
Publication of HK157896A publication Critical patent/HK157896A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
HK157896A 1984-03-01 1996-08-22 Pharmaceutical compositions HK157896A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH100884 1984-03-01
CH175384 1984-04-06

Publications (1)

Publication Number Publication Date
HK157896A true HK157896A (en) 1996-08-30

Family

ID=25686369

Family Applications (2)

Application Number Title Priority Date Filing Date
HK157896A HK157896A (en) 1984-03-01 1996-08-22 Pharmaceutical compositions
HK220096A HK220096A (en) 1984-03-01 1996-12-24 Pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK220096A HK220096A (en) 1984-03-01 1996-12-24 Pharmaceutical compositions

Country Status (18)

Country Link
EP (3) EP0155229B1 (enExample)
JP (2) JPH0667835B2 (enExample)
KR (1) KR920010392B1 (enExample)
AT (3) ATE89750T1 (enExample)
AU (2) AU578275B2 (enExample)
CA (1) CA1257837A (enExample)
DE (4) DE3587358T2 (enExample)
DK (2) DK175774B1 (enExample)
GR (1) GR850507B (enExample)
HK (2) HK157896A (enExample)
HU (1) HU197847B (enExample)
IE (2) IE61754B1 (enExample)
IL (1) IL74446A (enExample)
MY (1) MY101919A (enExample)
NZ (1) NZ211248A (enExample)
PH (1) PH24392A (enExample)
PT (1) PT80033B (enExample)
WO (1) WO1985003878A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
EP0808174B1 (de) * 1995-02-10 2003-05-07 Christian Noe Partikulare arzneiform
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
JP5758290B2 (ja) 2009-05-01 2015-08-05 久光製薬株式会社 経皮吸収型製剤
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
WO2018199018A1 (ja) * 2017-04-26 2018-11-01 ニプロ株式会社 経皮吸収型製剤およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
CH653256A5 (en) * 1981-04-06 1985-12-31 Sandoz Ag Microemulsion for cutaneous use
DE3271647D1 (en) * 1981-07-08 1986-07-17 Key Pharma Polymeric diffusion matrix containing propranolol
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物

Also Published As

Publication number Publication date
DE3587358T2 (de) 1993-11-04
IL74446A0 (en) 1985-05-31
HUT41644A (en) 1987-05-28
EP0315219B1 (en) 1993-01-27
DE3587358D1 (de) 1993-07-01
DE3587048D1 (de) 1993-03-11
GR850507B (enExample) 1985-06-28
EP0315218A2 (en) 1989-05-10
KR920010392B1 (ko) 1992-11-27
DK175774B1 (da) 2005-02-14
JPS61501324A (ja) 1986-07-03
DE3587698T2 (de) 1994-04-28
IE850493L (en) 1985-09-01
DK502985A (da) 1985-10-31
EP0315219A2 (en) 1989-05-10
DK164257B (da) 1992-06-01
WO1985003878A1 (en) 1985-09-12
DE3587794T2 (de) 1994-08-04
AU578275B2 (en) 1988-10-20
EP0315218A3 (en) 1991-03-06
AU607496B2 (en) 1991-03-07
DK164257C (da) 1992-10-19
EP0155229A3 (en) 1985-12-11
DE3587794D1 (de) 1994-05-11
PT80033B (pt) 1987-10-20
PH24392A (en) 1990-06-13
IE61754B1 (en) 1994-11-30
NZ211248A (en) 1988-10-28
DE3587048T2 (de) 1993-06-03
EP0315219A3 (en) 1991-03-06
AU4065085A (en) 1985-09-24
IE81316B1 (en) 2000-09-20
EP0155229A2 (en) 1985-09-18
DK324687D0 (da) 1987-06-25
PT80033A (en) 1985-03-01
KR850700218A (ko) 1985-12-26
DE3587698D1 (de) 1994-02-03
ATE103819T1 (de) 1994-04-15
DK502985D0 (da) 1985-10-31
EP0155229B1 (en) 1993-05-26
DK324687A (da) 1987-06-25
EP0315218B1 (en) 1993-12-22
CA1257837A (en) 1989-07-25
AU1662688A (en) 1988-10-20
JPH0667835B2 (ja) 1994-08-31
IL74446A (en) 1990-11-29
MY101919A (en) 1992-02-15
ATE98876T1 (de) 1994-01-15
JPH0748253A (ja) 1995-02-21
JP2540019B2 (ja) 1996-10-02
ATE89750T1 (de) 1993-06-15
HU197847B (en) 1989-06-28
HK220096A (en) 1997-01-03
IE940083L (en) 1985-09-01

Similar Documents

Publication Publication Date Title
US5364628A (en) Pharmaceutical compositions
EP0155229B1 (en) Pharmaceutical compositions
RU2428179C2 (ru) Препаративные формы лекарственных средств против слабоумия для чрескожного введения
EP1047409B1 (en) Tts containing an antioxidant
EP1503743B1 (en) Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
JPH09501398A (ja) 活性成分パッチ
CZ281991B6 (cs) Způsob výroby transdermálního therapeutického systému
CN113876740A (zh) 一种阿戈美拉汀的透皮贴剂
US6316023B1 (en) TTS containing an antioxidant
CN112915071A (zh) 一种含有美金刚的透皮贴剂
EP1847264B1 (en) Bisoprolol patch
EP0315217B1 (en) Pharmaceutical compositions
KR100439659B1 (ko) 툴로부테롤을 함유하는 경피흡수용 패취제
IE69475B1 (en) Pharmaceutical compositions
DK175236B1 (da) Farmaceutisk præparat
DK175982B1 (da) Farmaceutisk præparat til transdermal systemisk administration af et farmakologisk aktivt middel, fremgangsmåde til fremstilling af et præparat og anvendelse af et polyacrylat til fremstilling af et lægemiddel
HK1034036B (en) Tts containing an antioxidant
JP2002500178A5 (enExample)

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050221